NCT05179031View on ClinicalTrials.gov

Assessment of the Glycemic Responses to Nutritional Products

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

March 11, 2022

Study Completion Date

March 11, 2022

Conditions
Glycemic Response
Interventions
DIETARY_SUPPLEMENT

First Reference product (dextrose, containing 25 g of carbohydrates)

Reference dextrose solution containing 25 g of available carbohydrates

DIETARY_SUPPLEMENT

Second Reference product (dextrose, containing 25 g of carbohydrates)

Reference dextrose solution containing 25 g of available carbohydrates

DIETARY_SUPPLEMENT

Third Reference product (dextrose, containing 25 g of carbohydrates)

Reference dextrose solution containing 25 g of available carbohydrates

DIETARY_SUPPLEMENT

High protein tube feed

Nutritional product containing 25 g of available carbohydrates

DIETARY_SUPPLEMENT

High-protein tube feed with additional amino acid

Nutritional product containing 25 g of available carbohydrates

DIETARY_SUPPLEMENT

Oral Nutritional Supplement for diabetes patients

Nutritional product containing 25 g of available carbohydrates

DIETARY_SUPPLEMENT

Oral Nutritional Supplement for diabetes patients (new formula)

Nutritional product containing 25 g of available carbohydrates

DIETARY_SUPPLEMENT

ONS for disease related malnutrition

Nutritional product containing 25 g of available carbohydrates

DIETARY_SUPPLEMENT

Plantbased ONS for disease related malnutrition

Nutritional product containing 25 g of available carbohydrates

Trial Locations (1)

M5C 2N8

INQUIS Clinical Research, Ltd, Toronto

Sponsors

Lead Sponsor

Nutricia Research

Collaborators (1)

INQUIS Clinical Research
All Listed Sponsors
collaborator

INQUIS Clinical Research

INDUSTRY

lead

Nutricia Research

INDUSTRY